Shuttle Pharmaceuticals Holdings, Inc. (SHPH) — Institutional Holders, Q2 2026
5 institutional investment managers reported a SHPH position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $83.5K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
SHPH in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- CITADEL ADVISORSNew · +24,354 sh+$79.2K
- BARCLAYS PLCNew · +750 sh+$2.4K
- KELLEHER FINANCIAL ADVISORSAdded · +60 sh+$195.00
Biggest sellers
- Ikarian CapitalSold out · -6,899 sh-$22.4K
- GEODE CAPITAL MANAGEMENTSold out · -4,622 sh-$15.0K
- BOOTHBAY FUND MANAGEMENTSold out · -2,036 sh-$6.6K
- Virtu FinancialSold out · -1,238 sh-$4.0K
- UBS Group AGSold out · -567 sh-$1.8K
SHPH 13F holders ranked 1–5 of 5
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS#1 · 24,354 sh | 24,354 | $79.2K | 0.00% | New |
| 2 | BARCLAYS PLC#2 · 750 sh | 750 | $2.4K | 0.00% | New |
| 3 | Tower Research Capital (TRC)#3 · 389 sh | 389 | $1.3K | 0.00% | -91.6% |
| 4 | KELLEHER FINANCIAL ADVISORS#4 · 120 sh | 120 | $390.00 | <0.01% | -80.0% |
| 5 | HRT FINANCIAL#5 · 78,597 sh | 78,597 | $255.00 | 0.00% | New |
Funds that sold out of SHPH in Q2 2026 (6)
Held SHPH at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Ikarian Capital6,899 sh | 6,899 | $46.8K |
| GEODE CAPITAL MANAGEMENT4,622 sh | 4,622 | $31.4K |
| BOOTHBAY FUND MANAGEMENT2,036 sh | 2,036 | $13.8K |
| Virtu Financial1,238 sh | 1,238 | $8.0K |
| UBS Group AG567 sh | 567 | $3.9K |
| MORGAN STANLEY3 sh | 3 | $18.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.